A28 Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7660 Fay Ave # H-829, La Jolla, Californ...Website
www.a28therapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About A28 Therapeutics
A28 Therapeutics is a clinical stage biopharmaceutical company focused on developing targeted oncolytic peptides for the treatment of various cancer types. Their lead compound, AT-101, utilizes a novel platform technology that allows for high specificity in targeting tumor cells while minimizing toxicity to healthy cells. With over 70 pre-clinical studies and promising results from clinical trials, A28 aims to provide innovative cancer therapies that can be used in multiple treatment lines and combinations. The company is led by a team with 70 years of combined experience in life sciences, dedicated to advancing effective cancer treatments.Explore more
A28 Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is A28 Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if A28 Therapeutics had a recent Job posting/layoffs
Check if A28 Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at A28 Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on A28 Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
A28 Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once A28 Therapeutics has new funding data
Product Launch: Get notified when A28 Therapeutics launches new products
Check out if A28 Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at A28 Therapeutics
Find 3 more new buyers
Compare Similar Companies to A28 Therapeutics
Compare insights from companies similar to A28 Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
A28 Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
A28 Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about A28 Therapeutics.
A28 Therapeutics News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding A28 Therapeutics
Sign Up For FreeTo access detailed company insights
A28 Therapeutics is a clinical stage biopharmaceutical company focused on developing targeted oncolytic peptides for the treatment of various cancer types. Their lead compound, AT-101, utilizes a novel platform technology that allows for high specificity in targeting tumor cells while minimizing toxicity to healthy cells. With over 70 pre-clinical... Read More
